New initiative seeks investors’ help to tackle antimicrobial resistance
A coalition of public and private sector entities is looking to investors to help stem further growth in antimicrobial resistance (AMR).
Investor Year of Action on AMR, as their initiative has been dubbed, was launched in Davos, Switzerland, today, and has as its main objective “to leverage investor influence to make change happen”.
It is backed by the UK’s department of health and social care, Access to Medicine Foundation, the Principles for Responsible Investment, and FAIRR, a non-profit organisation working with investors on the topic of intensive animal production.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
